{
  "meta": {
    "disclaimer": "Do not rely on openFDA to make decisions regarding medical care. While we make every effort to ensure that data is accurate, you should assume all results are unvalidated. We may limit or otherwise restrict your access to the API in line with our Terms of Service.",
    "terms": "https://open.fda.gov/terms/",
    "license": "https://open.fda.gov/license/",
    "last_updated": "2026-08-21",
    "results": {
      "skip": 0,
      "limit": 1,
      "total": 1
    }
  },
  "results": [
    {
      "submissions": [
        {
          "submission_type": "SUPPL",
          "submission_number": "9",
          "submission_status": "AP",
          "submission_status_date": "20260630",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "86430",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2026/215309Orig1s009ltr.pdf",
              "date": "20260702",
              "type": "Letter"
            },
            {
              "id": "86507",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215309s009sdn953lbl.pdf",
              "date": "20260710",
              "type": "Label"
            },
            {
              "id": "86508",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2026/215309s009sdn953lbl.pdf#page=23",
              "date": "20260710",
              "type": "Medication Guide"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "7",
          "submission_status": "AP",
          "submission_status_date": "20250918",
          "review_priority": "STANDARD",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "83395",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2025/215309Orig1s007ltr.pdf",
              "date": "20250919",
              "type": "Letter"
            },
            {
              "id": "83397",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2025/215309s007lbl.pdf",
              "date": "20250919",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20220718",
          "review_priority": "PRIORITY",
          "submission_class_code": "EFFICACY",
          "submission_class_code_description": "Efficacy",
          "application_docs": [
            {
              "id": "71589",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/215309Orig1s001ltr.pdf",
              "date": "20220719",
              "type": "Letter"
            },
            {
              "id": "71592",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215309s001lbl.pdf",
              "date": "20220719",
              "type": "Label"
            },
            {
              "id": "85858",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2026/215309Orig1s001.pdf",
              "date": "20260511",
              "type": "Review"
            }
          ]
        },
        {
          "submission_type": "ORIG",
          "submission_number": "1",
          "submission_status": "AP",
          "submission_status_date": "20210921",
          "review_priority": "PRIORITY",
          "submission_class_code": "TYPE 10",
          "submission_class_code_description": "Type 10 - New Indication Submitted as Distinct NDA - Not Consolidated",
          "application_docs": [
            {
              "id": "68716",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2022/215309Orig1s000Corrected ltr.pdf",
              "date": "20210922",
              "type": "Letter"
            },
            {
              "id": "71520",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/nda/2022/215309Orig1s000TOC.html",
              "date": "20220706",
              "type": "Review"
            },
            {
              "id": "71552",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/label/2022/215309Orig1s000correctedlbl.pdf",
              "date": "20220714",
              "type": "Label"
            }
          ]
        },
        {
          "submission_type": "SUPPL",
          "submission_number": "4",
          "submission_status": "AP",
          "submission_status_date": "20230313",
          "review_priority": "STANDARD",
          "submission_class_code": "LABELING",
          "submission_class_code_description": "Labeling",
          "application_docs": [
            {
              "id": "73741",
              "url": "https://www.accessdata.fda.gov/drugsatfda_docs/appletter/2023/215309Orig1s004ltr.pdf",
              "date": "20230314",
              "type": "Letter"
            },
            {
              "id": "73759",
              "url": "http://www.accessdata.fda.gov/drugsatfda_docs/label/2023/215309s004lbl.pdf",
              "date": "20230314",
              "type": "Label"
            }
          ]
        }
      ],
      "application_number": "NDA215309",
      "sponsor_name": "INCYTE CORP",
      "openfda": {
        "application_number": [
          "NDA215309"
        ],
        "brand_name": [
          "OPZELURA"
        ],
        "generic_name": [
          "RUXOLITINIB"
        ],
        "manufacturer_name": [
          "Incyte Corporation"
        ],
        "product_ndc": [
          "50881-007"
        ],
        "product_type": [
          "HUMAN PRESCRIPTION DRUG"
        ],
        "route": [
          "TOPICAL"
        ],
        "substance_name": [
          "RUXOLITINIB PHOSPHATE"
        ],
        "rxcui": [
          "2570752",
          "2570757"
        ],
        "spl_id": [
          "af30042b-ecb2-4e8b-82be-117685dff4ed"
        ],
        "spl_set_id": [
          "24da5509-6631-4795-9d42-273faecd08e7"
        ],
        "package_ndc": [
          "50881-007-04",
          "50881-007-05",
          "50881-007-07",
          "50881-007-14"
        ],
        "unii": [
          "436LRU32H5"
        ]
      },
      "products": [
        {
          "product_number": "001",
          "reference_drug": "Yes",
          "brand_name": "OPZELURA",
          "active_ingredients": [
            {
              "name": "RUXOLITINIB PHOSPHATE",
              "strength": "EQ 1.5% BASE"
            }
          ],
          "reference_standard": "Yes",
          "dosage_form": "CREAM",
          "route": "TOPICAL",
          "marketing_status": "Prescription"
        }
      ]
    }
  ]
}